Diabefarm MV > Ọgwụgwọ na mgbochi

Diabefarm MV: Ntụziaka maka ojiji na nyocha

Aha Latin: Diabefarm MR

Koodu ATX: A10BB09

Ngwakọta ọrụ: Gliclazide (Gliclazide)

Onye na-emeputa ihe: Farmakor Production LLC (Russia)

Nkọwa na nwelite: 07/11/2019

Ahịa dị n'ụlọ ahịa ọgwụ: site na 95 rubles.

Diabefarm MV bụ ọgwụ nke hypoglycemic nke ọgwụ.

Mwepụta wepụtara ya na ihe mejupụtara

Usoro onunu ogwu nke Diabefarma MV:

Mbadamba tọhapụrụ nke edoziri: cylindrical, na-acha ọcha nke nwere mkpị osisi na-acha odo odo, yana ihe egwu nke chamfer na crosswise (na karamapa 1 otu mbadamba 60 ma ọ bụ 3 ma ọ bụ 6 na agba maka mbadamba 10),
Mpempe akwụkwọ ntọhapụ dịgidere: oval biconvex, nke fọrọ nke nta ka ọ dị ọcha ma ọ bụ nke nwere nchara na-acha odo odo, n'akụkụ abụọ nwere ihe ize ndụ (na blisters: na otu kaadiboodu 5 ngwugwu nke 6 PC., ma ọ bụ 3, 6, 9 nke 10 pcs., ma ọ bụ 5, 10 ngwugwu nke 12 PC., ma ọ bụ 2, 4, 6, 8 ngwugwu nke 15 PC.).

Otu obula nwekwara ntuziaka maka ojiji Diabefarma MV.

Ngwakọta 1 mbadamba:

ihe na-arụ ọrụ: gliclazide - 30 ma ọ bụ 60 mg,
ihe inyeaka: magnesium stearate, hypromellose, silloon silicon dioxide, celclose microcrystalline.

Mlọ ọgwụ

Glyclazide - ihe dị n'ime Diabefarma MV, bụ otu n'ime ọgwụ ọgwụ hypoglycemic nke a na-enweta na sulfonylureas nke ọgbọ nke abụọ.

Isi mmetụta nke gliclazide:

ihe mkpali nke insulin na - egbochi site na mkpụrụ ndụ
mụbara insulin na-arụpụta na mmetụta glucose,
mụbaa uru anụ ahụ nwere insulin,
mkpalite nke enzymes intracellular - akwara glycogen synthetase,
na -ebelata etiti oge site na iri nri ruo na mmalite insulin insulin,
mweghachi nke mbido insulin insulin (nke a bụ ihe dị iche n'etiti gliclazide na ihe ndị ọzọ ana - akpọ sulfonylurea, nke nwere mmetụta tumadi n'oge ọkwa nke abụọ nke nzuzo),
mbelata na mmụba postprandial na ọkwa glucose.

Na mgbakwunye na emetụta metabolism metabolism, gliclazide na-eme ka microcirculation dịkwuo mma: ọ na-ebelata nchịkọta platelet na nrapado, na-egbochi ọdịdị nke atherosclerosis na microthrombosis, na-eme ka ike gwụ vaskụla, ma weghachite physiological parietal fibrinolysis.

Ọzọkwa, mmetụta nke ihe a ka elele iji belata uche nke ndị na - anabata vaskụla na adrenaline ma belata mmalite nke ọrịa mamị retinopathy n’oge na - abụghị protinerative.

Megide ndabere nke iji ogologo oge nke Diabefarma MV na ndị ọrịa nwere ọrịa nephropathy, enwere nnukwu mbelata na proteinuria dị ukwuu. Ọ nwere mmetụta tumadi na mbido insulin insulin, ya mere, ọ dịghị ebute mmụba nke ahụ mmadụ ma ọ dịghị akpata hyperinsulinemia, ebe ị na-agbaso nri kwesịrị ekwesị na ndị ọrịa nwere oke ibu ọ na - enyere aka belata ibu.

Mlọ ọgwụ

Mgbe nchịkwa ọnụ gasịrị, a na-amị gliclazide site na eriri afọ eriri afọ kpamkpam. Ngwakọta plasma nke ihe na-arụ ọrụ na-abawanye nke nta nke nta, ọ ruru ogo ya na awa 6-12. Iri nri anaghị emetụta nnabata nke ọgwụ. Nkwurịta okwu na protein ndị na-edozi ahụ bụ ihe dị ka 95%.

Metabolism na - apata imeju, na - ebute uto nke metabolites na - adịghị arụ ọrụ. Iwepu ọkara ndụ bụ ihe dịka awa iri na isii. A na-emegharị anụ ahụ kachasị site na akụrụ n'ụdị metabolites, ihe dị ka 1% nke dose ahụ apụbeghị agbanwe.

N'ime ndị ọrịa mere agadi, enweghị mgbanwe mgbanwe dị mkpa na ọgwụ ọgwụ nke gliclazide hụrụ. Nlekọta kwa ụbọchị nke otu ọgwụ a na-enye ọgwụgwọ dị mma banyere ịgwọ ọrịa plasma nke ihe ahụ n'ime awa iri abụọ na anọ n'ihi njirimara nke usoro onunu ogwu.

Ihe ngbanwe

ụdị shuga 1
nnukwu ịba ọcha n'anya na / ma ọ bụ akụrụ ọdịda,
mamịrị ketoacidosis, ọrịa shuga, precca mamịrị, hyperosmolar coma,
paresis nke afọ, mgbochi afọ,
ọnya ọkụ dị ukwuu, ihe ndị metụtara ịwa ahụ dị ukwuu, mmerụ ahụ na ọnọdụ ndị ọzọ chọrọ ọgwụgwọ insulin,
leukopenia
ọnọdụ nke na-apụta site na ịba nri, mmepe nke hypoglycemia (ọrịa etiology na-efe efe),
ime na lactation,
afọ ruo afọ 18
mmadụ inabata ya na ọgwụ ndị ahụ.

Ikwu okwu (Diabefarm MV mbadamba kwesịrị iji nlezianya nlezianya):

ọrịa febrile
ọrịa thyroid na-eme nke mebiri ọrụ ya,
alisụrụma
nká.

Nsonaazụ

Ojiji nke Diabefarma CF dabere na nri na-ezughi ezu ma ọ bụ mebie usoro nchịkwa dosing nwere ike iduga mmepe nke hypoglycemia. A na-egosipụta ọgba aghara a site na isi ọwụwa, mmetụta nke ike ọgwụgwụ, oke iwe, adịghị ike dị ukwuu, agụụ, ọsụsọ, nchekasị, enweghị nchekasị, enweghị ike itinye uche, mmeghachi omume oge, ịda mbà, ọhụhụ isi, aphasia, mkpọtụ, mmetụta nke enweghị enyemaka, ọgba aghara mmetụta, ọnwụ nke njide onwe onye, nkụda mmụọ. , delirium, ịba ọcha n'anya, nkwarụ, enweghị mmụọ, bradycardia, iku ume.

Ihe omume ndi ozo di egwu:

akụkụ akwara nri: dyspepsia (egosipụta n'ụdị ọgbụgba, afọ ọsịsa, mmetụta nke oke na epigastrium), anorexia (ogo nke ọgba aghara a na-ebelata ọgwụ mgbe ị na-eri nri), ọrụ ịba ọcha n'anya (ịba ụba nke ọrụ hepatic transaminases, cholestatic jaundice),
hematopoiesis: thrombocytopenia, anaemia, leukopenia,
Mmeghachi omume nfụkasị ahụ: maculopapular rash, urticaria, pruritus.

Dodoụbiga ya ókè

Ihe mgbaàmà bụ isi: hypoglycemia ruo hypoglycemic coma.

Usoro ọgwụgwọ: oriri nke carbohydrates na-adị ngwa ngwa (shuga), ma ọ bụrụ na onye ọrịa ahụ amabeghị, a na-egosipụta nchịkwa nchịkwa nke 40% nke glucose (dextrose), nchịkwa intramuscular nke 1-2 mg nke glucagon. Mgbe eweghachiri mmụọ, a ga-enyerịrị onye ọrịa ahụ nri nwere carbohydrates na-agbari ngwa ngwa iji zere ịmaliteghachi hypoglycemia.

Ntụziaka pụrụ iche

Were Diabefarm MV kwesịrị ijikọ nri nwere obere kalori, gụnyere obere carbohydrates. Nlegide anya nke glucose ọbara na-ebu ọnụ yana mgbe ị gachara nri achọrọ.

Mgbe ị na-agbasa ọrịa shuga ma ọ bụ n'ihe gbasara ịwa ahụ, a ga-atụle ohere nke iji insulin kwadebe ya.

N’iburu ọnụ, na-a nonụ ọgwụ mgbochi na-abụghị steroidal ma ọ bụ ethanol, ohere nke hypoglycemia na-abawanye.

Site na oke mmetụta uche ma ọ bụ nke anụ ahụ, mgbanwe nri, ịkwesịrị ịhazigharị ọgwụ.

Ndị ọrịa nwere nkụda mmụọ na ndị ọrịa nwere ọrịa pituitary-adrenal, yana ndị agadi na anaghị enweta nri edozi, na-emetụta mmetụta nke Diabefarm MV.

Mkparịta ụka ọgwụ ọjọọ

A na - eme ka mmetụta hypoglycemic nke Diabefarma MV site na ọgwụ ndị na - esote: angiotensin-converting enzyme inhibitors (enalapril, captopril), ndị na - egbochi N₂Ndị na-anabata ọgwụ (ọgwụ cimetidine), ọgwụ anabolic steroid, coumarin anticoagulants, monoamine oxidase inhibitors, β-blockers, ndị ọrụ antifungal (fluconazole, miconazole), tetracycline, ọgwụ anti-inflammatory ọgwụ na-adịghị mma (indomethazone bisenofenaoneenaenaenaenaena) (clofibrate, bezafibrate), salicylates, cyclophosphamide, sulfonamides na-adịgide adịgide, fluoxetine, fenfluramine, reserpine, ọgwụ mgbochi TB (ethionamide), chloramphenic ol, pentoxifylline, theophylline, guanethidine, ọgwụ na-egbochi tubular secretion, bromocriptine, obedipyramide, allopurinol, pyridoxine, ethanol na nkwadebe ndị nwere ethanol, yana ndị ọrụ hypoglycemic ndị ọzọ (biguanides, acarbose, insulin).

Mmetụta hypoglycemic nke Diabefarma MV adịghị ike mgbe ejikọtara ya na barbiturates, glucocorticosteroids, sympathomimetics (epinephrine, clonidine, rhytodrin, salbutamol, terbutaline), thiazide diuretics, diazoxide, isoniazid, chlololololololo, ), morphine, triamteren, asparaginase, baclofen, danazole, rifampicin, nnu nke lithium, homonụ thyroid, na oke onunu ogwu - chlorpromazine, nicotinic acid, estrogens na ọgwụ mgbochi ọnụ nwere ya.

Mkparịta ụka ndị ọzọ enwere ike:

ọgwụ ndị na-egbochi ụmị ọkpụkpụ hematopoiesis: ihe myelosuppression na-abawanye,
ethanol: mgbe ejikọtara, mmeghachi omume disulfiram nwere ike ime,
obi glycosides: ihe ize ndụ nke ventricular extrasystole na-abawanye,
guanethidine, clonidine, β-blockers, reserpine: megide nzụlite nke ijikọtara ọnụ, enwere ike ịmịpụta ngosipụta nke hypoglycemia.

Analogs nke Diabefarm MV bụ: Gliclada, Glidiab, Gliclazide MV, Gliclazide-AKOS, Glucostabil, Diabetalong, Golda MV, Diabefarm, Diabeton MV, Diatika, Diabinaks, Reklid, Predian na ndị ọzọ.

Uzo eji eme ihe na ihe omimi banyere iji ogwu

Diabefarm bụ ihe eji arụ ọrụ hypoglycemic na-arụ ọrụ, ihe kachasị arụ ọrụ na ya bụ glyclazide. A na-eji mmiri ara ehi eme ihe, magnesium stearate na povidone dịka ngwa ndị ọzọ.

Mgbanwe ọgwụ na ahụ

Diabefarm site na mkpo ya bidoro na akwara ọnụ, ma emesịa na-akwụsị na mpaghara ala akụkụ eriri afọ. Ntinye uche kachasị maka ọgwụ na ọbara mgbe nchịkwa pụtara mgbe awa atọ ma ọ bụ anọ gasịrị, nke na-egosi ị aụ ọgwụ ahụ nke ọma.

A na - eme Diabefarm excretion mgbe ọ rụchara ya na imeju ma mikpuo metabolites. Akụkụ bụ isi nke ọgwụ ahụ bụ akụrụ na eriri afọ ya na-enwe ọria yana mmamịrị, ọ bụ naanị obere akụkụ ka akpụkpọ ahụ wepụrụ. Oge ikpeazu ọcha nke anụ ahụ ga-abụ site n’awa asaa ruo iri abụọ na otu.

Releasedị nke ịhapụ ọgwụ

Andzọ izipu Diabefarm bụ mbadamba ihe na-enweghị shei. Otu mbadamba ihe nwere 0.08 gram nke ihe eji eme ihe. A na-etinye ọgwụ ahụ na ngwugwu okirikiri nke ihe nkiri na foil, nke nwere mbadamba iri. N'ime otu kaadiboodu na ọgwụ ahụ, ọ dabere na ọnụọgụ ha, enwere ike ịnwe ngwugwu ekwentị atọ ma ọ bụ isii.

Yabụ, na shelves nke ụlọ ahịa ọgwụ ị nwere ike ịchọta Diabefarm na ọnụ ọgụgụ mbadamba iri atọ na isii.

Ntụziaka maka ojiji

Diabefarm, onye ntuziaka maka iji ya dị oke mfe, ịkwesịrị ị were mbadamba abụọ ụbọchị tupu nri. Mustụ ọgwụ ahụ ga-ebu ụzọ nyocha nke glucose ọbara.

A na-eji ọgwụ eme ọgwụ: a ga-eji iko mmiri hichaa mbadamba ahụ, dị ka ihe ọ carbonụ carbonụ carbonated na ihe ọ acidụ acidụ acidic na ihe oriri nwere ike imetụta mmetụta nke ọgwụ.

Mmekọrịta nke ọgwụ ya na ọgwụ ọgwụ ndị ọzọ

Ọ bụrụ na ọtụtụ ọgwụ na-abanye n’ahụ otu oge, mmeghachi ọgwụ kemịkal nwere ike ime n’etiti ha. Ngbanwe ndị a nwere ike ịkwalite, belata ma ọ bụ mebie mmetụta nke ọgwụ.

Mmetụta nke mmekọrịta Diabefarm na ọgwụ:

onye na-ahụ maka antifungal miconazole na-abawanye ike hypoglycemic,
Chlorpromazine na-abawanye oke glucose na ọbara, nke chọrọ mmezi dose maka Diabefarm.
Insulin na ọgwụ mgbochi ọgwụ ndị ọzọ na - akwalite mmetụta ị takingụ Diabefarm,
Salmoterol, terbutaline na-abawanye shuga ọbara, na-ebelata mmetụta hypoglycemic nke ọgwụ.

Nsonaazụ

Ọgwụ diabepharm MV 30 mg, ọnụahịa, ntuziaka na nyocha banyere nke ị nwere ike ịnụ na ụlọ ahịa ọgwụ ọ bụla, dị ka ọgwụ ọ bụla, nwere ọtụtụ mmetụta. Otutu n'ime ha na-akpata site na mgbanwe ndi otu ogwu na aru.

Nsonaazụ Diabepharm MV:

isi ọwụwa nke ogo dịgasị iche, ike isi,
ọgbụgbọ, vomiting,
afọ ọsịsa ma ọ bụ afọ ntachi,
na-ekpu ume na mbuze n'ime eriri afọ,
akpịrị na mmiri na -eme ihe ọjọọ n'anya
nsogbu ụra
agụụ a na-achịkwaghị achịkwa
ịba ụba na-eme ihe ike na echiche nke nchegbu,
echiche nke ịda mba,
nsogbu ụkọ, egwu nke akaji,
mmepe nke anaemia na agranulocytosis,
Mmeghachi omume nfụkasị: ụbụrụ Quincke, urticaria, ihe ọnụnọ, itching, peeling nke anụ ahụ, ọnya erythematous, ọnya akpụkpọ ahụ, akọrọ mucous,
gbasara akwara na ọrịa ịba ọcha n'anya,
ibelata ma nwekwuo ume n’obi,
nsogbu iku ume
mgbu na hypochondrium ziri ezi,
ọnwụ nke mmụọ.

Diabefarm MV bụ onye nnọchi anya kachasị mma na ọnụahịa ọnụahịa ya. Ọ bụrụ na ịmalite site ná nkezi ọnụ ahịa ọgwụ ahụ n'obodo dị iche iche, mgbe ahụ ọ ga-adị iche iche.

Ego maka ọgwụ ọgwụ n'obodo dị iche iche:

Na Moscow, enwere ike ịzụta ọgwụ site na 126 rubles n'otu mkpọ nke mbadamba iri atọ, yana ihe ruru 350 rubles n'otu ngwugwu nke mbadamba iri isii.
Na St. Petersburg, ọnụahịa ọnụahịa sitere na 115 ruo 450 rubles.
Na Chelyabinsk, enwere ike ịzụta ọgwụ ahụ maka 110 rubles.
Na Saratov, ọnụ ahịa sitere na 121 ruo 300 rubles.

Diabefarm bụ ọgwụ ọgwụ analorọ juru n'ọtụtụ ọgwụ obodo nke mba ahụ. Onye ọrịa ahụ nwere ike ikpebiri onwe ya ma ọ̀ ka mma - dochie ma ọ bụ ọgwụ n’onwe ya.

Ndepụta nke analogues nke Diabefarm:

Ọrịa mamịrị. Ihe mejupụtara ọgwụ a dị ka Diabepharma, mana ọ na-emetụta oke nke abụọ nke insulin na-egbochi, na-egbochi igbochi oke abụba ahụ. Diabefarm ma ọ bụ ọrịa shuga - nhọrọ doro anya. Ọnụahịa ọgwụ ahụ bụ 316 rubles.
Glyclazide - enweghị ihe inyeaka na ihe mejupụtara ya, nke na-enyere aka nwayọ n ’ọgwụ n’ahụ. Ọ na-amịpụta ihe ka ukwuu n'ọgwụ ọgwụ ahụ site akụrụ n'ụdị na-enweghị mgbanwe. Ọnụ ego ọgwụ ahụ bụ 123 rubles.
Glidiab fọrọ nke nta enweghị mmetụta na-eme ka ọ kwụsie ike na mgbidi akwara, n'adịghị ka Diabepharm. Ọzọkwa enweghị mmetụta cholestatic. Ọnụ ahịa ya bụ 136 rubles.
Glucostabil nwere silica na lactose monohydrate dị ka ndị nke ochie. Enweghị ike iji ọgwụ a mee ihe n'ebe ndị mmadụ na-anagide nri lactose. Ọnụahịa dị na ụlọ ahịa ọgwụ bụ 130 rubles.

Weputara udi ya na ihe mebere ya

Ogwu a di n ’ụdị mbadamba ihe na ndozi emere. Ha nwere udi dị larịị, na mbadamba ụrọ nke ọ bụla nwere akara ekeresịrị ekeresimesi. Agba ọcha ma ọ bụ ude.

Isi ihe na-arụ ọrụ bụ gliclazide. Otu mbadamba 1 nwere 30 mg ma ọ bụ 80 mg. Ihe ndi ozo: povidone, shuga mmiri ara ehi, magnesium stearate.

A na-emepụta ọgwụ ahụ na mbadamba ihe dị mbadamba 10 ọ bụla (na mbadamba kaadiboodu enwere blisters 6) yana mbadamba 20 n'ime mkpọ, na ngwugwu kaadi 3 3 blisters. Ọzọkwa, ọgwụ ahụ dị na karama rọm nke 60 ma ọ bụ 240 iberibe ọ bụla.

Omume ọgwụ

Mbadamba ụrọ nwere ike sitere na usoro nke abụọ nke usoro sulfonylurea. Site na iji ha, mkpali nke insulin na-enyocha ihe site na mkpụrụ ndụ beta nke pancreas na-apụta. N’ụdị a, mmetụta anụ ahụ na - emetụta insulin na-abawanye.Ọrụ nke enzymes n’ime mkpụrụ ndụ na-abawanye. Oge dị n'etiti iri nri na mmalite insulin insulin na-ebelata nke ukwuu.

Mbadamba ụbụrụ na-egbochi mmepe nke atherosclerosis na ọdịdị microthrombi.

Gliclazide na-ebelata nrapado platelet na nchịkọta. Mmepe nke ọrịa ọgbụgba ọbara parietal na-akwụsị, ọrụ fibrinolytic nke arịa ahụ na-abawanye. Ike nke mgbidi vaskụla na-alaghachi na nkịtị. Rationta cholesterol n'ime ọbara na-ebelata. A na-ebelatakwa ọkwa nke radicals n'efu. Mbadamba ụbụrụ na-egbochi mmepe nke atherosclerosis na ọdịdị microthrombi. Microcirculation na-akawanye mma. Mmetụta nke akwara ọbara na adrenaline na-ebelata.

Mgbe ọrịa mamịrị nephropathy mere n'ihi ọgwụ ogologo oge, proteinuria na-ebelata.

Na-egosi Diabefarma MV

A na-atụ aro ọgwụ ahụ maka mgbochi nke ụdị shuga 2. Ọ na - enyere aka igbochi microvascular ga - ekwe omume (n'ụdị nke retinopathy na nephropathy) yana nsogbu macrovaskụla, dị ka infarction myocardial.

Na mgbakwunye, a gosipụtara ọgwụ ahụ maka ọrịa shuga 2, ọ bụrụ na nri, mmega ahụ na ịta ahụ anaghị enye nsonaazụ. Jiri ya yana mmebi nke microcirculation na ụbụrụ.

Etu esi eji: usoro onunu ogwu na usoro ọgwụgwọ

N'ime, n'oge nri, usoro mbụ kwa ụbọchị bụ 80 mg, nkezi kwa ụbọchị nke Diabefarm MV bụ 160-320 mg (na 2 usoro, n'ụtụtụ na mgbede). Hà ịgwọ ya dabere n’afọ, ogo nke ọrịa shuga, ịba n’ole glucose ọbara na-ebu ọnụ na awa 2 mgbe ị risịrị nri.

A na-ewere mbadamba 30 mg agbanwe mbadamba otu ugboro kwa ụbọchị na nri ụtụtụ. Ọ bụrụ na ọgwụ ahụ funahụrụ ya, yabụ echi ya ekwesịghị ịba ụba ọgwụ a. Usoro ọgwụgwọ akwadoro nke mbụ bụ mg mg 30 (gụnyere maka ndị ruru 65). Enwere ike ịgbanwe mgbanwe ọ bụla na - esote izu ma ọ dịkarịa ala izu abụọ. Ọgwụ Diabefarma MV kwa ụbọchị ekwesịghị ịfe 120 mg. Ọ bụrụ na onye ọrịa enwetaburu ọgwụgwọ na sulfonylureas nwere ogologo T1 / 2, nlezianya nlezianya (izu 1-2) dị mkpa iji zere hypoglycemia n'ihi nrụgide nke nsonaazụ ha.

Usoro ọgwụgwọ usoro maka Diabefarma MV maka ndị ọrịa agadi ma ọ bụ na ndị ọrịa nwere obere mkpesa na-adịghị ala ala (CC 15-80 ml / min) bụ otu ihe ahụ dị n'elu.

Na insulin, a na-atụ aro mg 60-180 ka ụbọchị dum.

N'ime ndị ọrịa n'ihe ize ndụ nke ịmalite hypoglycemia (nri na-ezighi ma ọ bụ nke na-adịghị edozi ahụ, nkwarụ endocrine na-adịghị ala ala ma ọ bụ nke na-adịghị mma, gụnyere pituitary na adrenal insufficiency, hypothyroidism, hypopituitarism, kagbuo glucocorticosteroids mgbe nchịkwa ogologo na / ma ọ bụ nchịkwa na oke doses, ọnya akwara siri ike, tinyere ọrịa akwara siri ike, akwara arteriosclerosis siri ike, ọrịa atherosclerosis na-ekwukarị iji obere opekata mpe nke 30 mg (maka mbadamba nkume nwere oke agbago elu. obozhdeniem).

Jiri na agadi

A na-adụ ndị okenye ọdụ ka ha jiri nlekọta dị mma were ọgwụ a, n'ihi thisdị ndị a nọ n'ihe ize ndụ nke ịmalite hypoglycemia. N'ime ndị okenye, mmeghachi omume ojoo na-eme ọtụtụ mgbe. Ọ dị ha mkpa ịdị na-enyocha ọkwa glucose ọbara ha mgbe niile.

A na-adụ ndị okenye ọdụ ka ha jiri nlekọta dị mma were ọgwụ a, n'ihi thisdị ndị a nọ n'ihe ize ndụ nke ịmalite hypoglycemia.

Mmekọrịta na ọgwụ ndị ọzọ

Mmetụta hypoglycemic na-abawanye na oge nke mbadamba nkume nwere ihe dị iche iche nke pyrazolone, ụfọdụ salicylates, sulfonamides, phenylbutazone, caffeine, theophylline na MAO inhibitors.

Ndị na-egbochi adrenergic na-emeghị nhọrọ na-abawanye ohere nke hypoglycemia. N'okwu a, mkpọtụ, tachycardia na-apụtakarị, sweating na-abawanye.

Mgbe ejikọtara ya na acarbose, a na-achọpụta mmetụta hypoglycemic na-agbakwunye. Cimetidine na - eme ka ihe na - arụ ọrụ n'ime ọbara, nke a na - eduga na mgbochi nke usoro ụjọ ahụ na - emetụta mmụọ.

Ọ bụrụ n’ị simụ otu oge, na-a diụ ọgwụ diiri, ihe nri, estrogens, barbiturates, rifampicin, mmetụta hypoglycemic nke ọgwụ a belatara.

Mmanya ndakọrịta

Ejila ogwu oge oge mmanya. Nke a nwere ike ibute mmụba nke mmanya mmịrị, nke ihe mgbu na-egosipụta, n'ime ọgbụgbọ, ọgbụgbọ, na isi ọwụwa.

Diabefarm nwere ọtụtụ analogues nke yitere ya na usoro nke ihe arụ ọrụ na ọgwụgwọ ọgwụgwọ. Kacha nkịtị n’ime ha bụ:

Pịa
Glidiab
Glyclazide Canon,
Glyclazide-AKOS,
Ọrịa mamịrị
Diabetalong
Diabinax.

Diabefarm MV nkuzi mmịnye ogwu Diabeton Glidiab nkuzi

Emeputa

Companylọ ọrụ na-emepụta: Farmakor, Russia.

Ihe ọgwụ a na - eme n'oge a na - enye akwa ọgwụ.

Imirikiti ndị dọkịta, dị ka ndị ọrịa, na-anabata ọgwụ a.

Ndị ọrịa mamịrị

Marina, dị afọ 28, Perm

Mpempe akwụkwọ Diabefarma MV gbanwere site na Diabeton. Enwere m ike ikwu na arụmọrụ nke ihe dị elu dị elu. Enweghị mmeghachi omume ọjọọ ọ bụla mere; Ana m akwado ya.

Pavel, gbara afọ 43, Simferopol

Anaghị m akwado ọgwụ a. Na mgbakwunye na iwere ya mgbe niile, iwe na-ewe m nke ukwuu, enwere m nkụda mmụọ oge niile, ana m enwekwa nsogbu mgbe niile. Ọbara ọbara dị ala. To gha bulie ọgwụ ọzọ.

Ksenia, onye gbara afọ 35, St. Petersburg

Ogwu a dị ọnụ ala ma na -efe ọrịa adịghị njọ karịa analogues dị oke ọnụ. Ọbara glucose weghachitere n’onwe m, ahụ bịara dị m mma na nchekwube. Nri ka kwesịrị ịdị, mana ọ bụghị otu oge. N'oge nnabata, enweghị mmetụta ọ bụla yana mba.

Mikhailov V.A., endocrinologist, Moscow

A na-enyekarị Diabefarma MV mbadamba maka ndị nwere ọrịa shuga 2. Ha malitere ịtọhapụ ya n'oge na-adịbeghị anya, mana ọ jisiri ike gosipụta onwe ya n'akụkụ dị mma. Imirikiti ndị ọrịa, malite ị itụ ya, ahụ dị ha mma, anaghị eme mkpesa maka mmeghachi omume ọjọọ. Ọ bụ ihe na-agaghị ekwe ọnụ, nke bụkwa nkọwa gbakwunyere na.

Soroka L.I., endocrinologist, Irkutstk

N'omume m, ana m ejikarị ọgwụ a. E nwere nanị otu ikpe nke nnukwu hypoglycemia na-arịa ọrịa shuga. Nke a bụ ezigbo ọnụ ọgụgụ. Ndị ọrịa na-eji ya eme ihe mgbe niile na-achọpụta idobe ụkpụrụ glucose.